Subgroup | Whole cohort (n=318) | Hospital attenders (n=238) |
RA at baseline (n=160) | RA—hospital attenders (n=138) |
Female (No (%)) | 213 (67.0) | 160 (67.2) | 108 (67.5) | 94 (68.1) |
Age at follow up (years), median (IQR) | 60 (47–71) | 59.5 (47–71) | 61 (50–72.5) | 60.5 (50–72) |
Symptom duration at follow up (years), median (IQR) | 5.5 (5.2–5.9) | 5.5 (5.2–5.9) | 5.5 (5.2–6.0) | 5.6 (5.2–6.0) |
Pain VAS, median (IQR) | 4 (2–6) | 4 (2–6) | 4 (2–7) | 5 (2–7) |
HAQ, median (IQR) | 0.75 (0.25–1.50) | 0.875 (0.25–1.75) | 1.06 (0.375–1.81) | 1.125 (0.375–1.875) |